Medical/Pharma. Monday. edMira Attends FDA Publ

Medical/Pharma. Monday.

• edMira Attends FDA Public Workshop as Interest in its Multiplex Rapid Tests Continues to Increase
  7:15 am - CNW Group


• Emergent BioSolutions Announces Positive Preclinical Efficacy and PK Data for Its New Bispecific Adaptir Protein Therapeutic ES414 at AACR
  7:15 am - Business Wire


• Amyris Scientists Describe Breakthrough in Development of Anti-Malarial Drug Precursor
  7:08 am - GlobeNewswire


• Covidien and VIDA Diagnostics Collaborate to Expand Minimally Invasive Treatment of Lung Disease
  7:00 am - Business Wire


• Theratechnologies Announces Financial Results for First Quarter of 2013
  7:00 am - Marketwire


• Peter Dinklage Joins Cruelty Free International to Call for US ban on Animal Tests for Cosmetics
  7:00 am - PR Newswire


• Rite Aid Reports Net Income and Record Adjusted EBITDA for Fourth Quarter and Full 2013 Fiscal Year
  7:00 am - Business Wire


• Elizabeth Rushforth Joins MedeAnalytics as General Counsel
  7:00 am - PR Newswire


• Boston Therapeutics Requests an IND Meeting With the FDA for PAZ320 to Reduce Postprandial Hyperglycemia in Type 2 Diabetes
  7:00 am - Marketwire


• ACADIA Pharmaceuticals Announces Expedited Path to NDA Filing for Pimavanserin Following Meeting with FDA
  7:00 am - Business Wire


• Humetrix Featured at TEDMED 2013
  7:00 am - Marketwire


• Hawaii Biotech Gains Rights to West Nile Vaccine Technology From Merck
  7:00 am - Marketwire


• Gamida Cell Reports StemEx® Phase II/III Study Safety and Efficacy Data
  7:00 am - Business Wire


• Theratechnologies annonce ses résultats financiers pour le premier trimestre de 2013
  7:00 am - Marketwire


• Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
  6:30 am - PR Newswire


• Houston Bariatric Surgeons Help Patients With Financing Their Surgery
  6:01 am - Marketwire


• Toshiba’s MR Smart Fusion Ultrasound Technology Improves Interventional Accuracy
  6:00 am - Business Wire


• Investigator at The Saban Research Institute Discovers Key Factor Involved in Generating Insulin-Producing Beta Cells
  6:00 am - Business Wire


• Cydan, a New Orphan Drug Accelerator, Launches with $16 Million Financing from Leading Investors NEA, Pfizer Venture Investments and Alexandria Real Estate Equities
  6:00 am - Business Wire


• Elekta Receives U.S. FDA 510(k) Clearance Following Launch of New Versa HD Radiation Therapy System for Cancer Treatment
  5:13 am - Business Wire


• DiaGenic ASA: DiaGenic Patent Allowed in Canada
  5:10 am - Business Wire


• ArcDia International Ltd, the Multianalyte Point-of-Care Company for Infectious Diseases, Strengthens Management
  5:06 am - PR Newswire


• Ashburn Plastic Surgeon Highlights Benefits of Breast Reduction Surgery
  5:03 am - Marketwire


• Less Is More: New York Dentist Uses Minimally Invasive Techniques to Achieve Natural Looking Smiles
  5:01 am - Marketwire


• Fat Grafting and Breast Augmentation Workshop in New York City Ahead of ASAPS 2013
  5:01 am - Marketwire


• Move Your Workout and Your Family Outdoors
  5:00 am - Marketwire


• Market Research Report -- North American Injectable Drug Delivery Market to Reach $16.6 Billion by 2017
  4:08 am - Marketwire


• Results from Cardio3BioSciences C-CURE® Trial Published in the Journal of the American College of Cardiology
  4:00 am - PR Newswire


• Oramed Submits New IND Application for Oral Insulin Trial in the US
  3:11 am - PR Newswire


• United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension
  3:00 am - GlobeNewswire


• Active Biotech - Notice of Annual General Meeting of Shareholders
  2:54 am - Marketwire